BACKGROUND: Both environmental and genetic factors are involved in the etiology of NTDs. Inadequate folate intake and obesity are important environmental risk factors. Several folate-related genetic variants have been identified as risk factors; however, little is known about how genetic variants relate to the increased risk seen in obese women. Uncoupling Protein 2 (UCP2) is an attractive candidate to screen for NTD risk because of its possible role in obesity as well as energy metabolism, type-2 diabetes, and the regulation of reactive oxygen species. Interestingly, a previous study found that a common UCP2 compound homozygous genotype was associated with a threefold increase in NTD risk. METHODS: We evaluated three polymorphisms, -866G>A, A55V, and the 3'UTR 45 bp insertion/deletion, as risk factors for NTDs in Irish NTD cases (n = 169), their mothers (n = 163), their fathers (n = 167), and normal control subjects (n = 332). RESULTS: Allele and genotype frequencies were not significantly different when comparing NTD mothers, NTD fathers, or affected children to controls. Additionally, the previously reported risk genotype (combined homozygosity of 55VV and 3'UTR 45 bp deletion/deletion) was not present at a higher frequency in any NTD group when compared to controls. CONCLUSIONS: In our Irish study population, UCP2 polymorphisms did not influence NTD risk. Moreover, the prevalence of this allele in other populations was similar to the Irish prevalence but far lower than reported in the previous NTD study, suggesting that this previous finding of an association with NTDs might have been due to an unrepresentative study sample. (c) 2009 Wiley-Liss, Inc.
BACKGROUND: Both environmental and genetic factors are involved in the etiology of NTDs. Inadequate folate intake and obesity are important environmental risk factors. Several folate-related genetic variants have been identified as risk factors; however, little is known about how genetic variants relate to the increased risk seen in obesewomen. Uncoupling Protein 2 (UCP2) is an attractive candidate to screen for NTD risk because of its possible role in obesity as well as energy metabolism, type-2 diabetes, and the regulation of reactive oxygen species. Interestingly, a previous study found that a common UCP2 compound homozygous genotype was associated with a threefold increase in NTD risk. METHODS: We evaluated three polymorphisms, -866G>A, A55V, and the 3'UTR 45 bp insertion/deletion, as risk factors for NTDs in Irish NTD cases (n = 169), their mothers (n = 163), their fathers (n = 167), and normal control subjects (n = 332). RESULTS: Allele and genotype frequencies were not significantly different when comparing NTD mothers, NTD fathers, or affected children to controls. Additionally, the previously reported risk genotype (combined homozygosity of 55VV and 3'UTR 45 bp deletion/deletion) was not present at a higher frequency in any NTD group when compared to controls. CONCLUSIONS: In our Irish study population, UCP2 polymorphisms did not influence NTD risk. Moreover, the prevalence of this allele in other populations was similar to the Irish prevalence but far lower than reported in the previous NTD study, suggesting that this previous finding of an association with NTDs might have been due to an unrepresentative study sample. (c) 2009 Wiley-Liss, Inc.
Authors: C Y Zhang; G Baffy; P Perret; S Krauss; O Peroni; D Grujic; T Hagen; A J Vidal-Puig; O Boss; Y B Kim; X X Zheng; M B Wheeler; G I Shulman; C B Chan; B B Lowell Journal: Cell Date: 2001-06-15 Impact factor: 41.582
Authors: Franz Krempler; Harald Esterbauer; Raimund Weitgasser; Christoph Ebenbichler; Josef R Patsch; Karl Miller; Mingqiang Xie; Veronika Linnemayr; Hannes Oberkofler; Wolfgang Patsch Journal: Diabetes Date: 2002-11 Impact factor: 9.461
Authors: Gary M Shaw; Thu Quach; Verne Nelson; Suzan L Carmichael; Donna M Schaffer; Steve Selvin; Wei Yang Journal: Am J Clin Nutr Date: 2003-11 Impact factor: 7.045
Authors: María C Ochoa; José L Santos; Cristina Azcona; María J Moreno-Aliaga; Miguel A Martínez-González; J Alfredo Martínez; Amelia Marti Journal: Mol Genet Metab Date: 2007-09-17 Impact factor: 4.797
Authors: Hua Wang; Winston S Chu; Tong Lu; Sandra J Hasstedt; Philip A Kern; Steven C Elbein Journal: Am J Physiol Endocrinol Metab Date: 2003-08-12 Impact factor: 4.310
Authors: Louise T Dalgaard; Gitte Andersen; Lesli H Larsen; Thorkild I A Sørensen; Teis Andersen; Thomas Drivsholm; Knut Borch-Johnsen; Jan Fleckner; Torben Hansen; Nanni Din; Oluf Pedersen Journal: Obes Res Date: 2003-11
Authors: Philip J Lupo; Mark A Canfield; Claudia Chapa; Wei Lu; A J Agopian; Laura E Mitchell; Gary M Shaw; D Kim Waller; Andrew F Olshan; Richard H Finnell; Huiping Zhu Journal: Am J Epidemiol Date: 2012-11-06 Impact factor: 4.897
Authors: Tonia C Carter; Faith Pangilinan; James F Troendle; Anne M Molloy; Julia VanderMeer; Adam Mitchell; Peadar N Kirke; Mary R Conley; Barry Shane; John M Scott; Lawrence C Brody; James L Mills Journal: Am J Med Genet A Date: 2010-12-10 Impact factor: 2.802